Mark Hopman

Chief Commercial Officer

Mark Hopman (Chief Commercial Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales, 1 filed past the two-business-day deadline), most often in Beta Bionics, Inc. (BBNX). The largest single filing was $665K of BBNX (35,994 sh × $18.46, as filed), executed Sep 9.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 3 sells · 1 late

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.4M

shares × price, as filed

Last traded

Sep 16

Filed Sep 17

Median ADV $22.9M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names

BBNX

Beta Bionics, Inc. BBNX · 0 buys · 5 sells 5 filings

Recent filings

BBNXSALE Beta Bionics, Inc. View filing → $620K
30,779 sh × $20.13
Exec Sep 16
Filed Sep 17 · 4:15 PM ET BBNXSALE Beta Bionics, Inc. View filing → $665K
35,994 sh × $18.46
Exec Sep 9
Filed Sep 18 · 7:51 PM ET † BBNXSALE Beta Bionics, Inc. View filing → $102K
5,327 sh × $19.11
Exec Sep 2
Filed Sep 3 · 6:15 PM ET BBNXSALE Beta Bionics, Inc. View filing → $371K
18,229 sh across 2 lots
Exec Sep 4 2025
Filed Sep 8 2025 · 5:30 PM ET BBNXSALE Beta Bionics, Inc. View filing → $268K
16,158 sh × $16.61
Exec Aug 19 2025
Filed Aug 20 2025 · 5:30 PM ET